LATS2 and breast carcinoma: Consistent with this notion, the loss of heterozygosity of LATS1 [10,11,12] and frequent copy number loss of LATS2 [13] has been reported in breast cancer, suggesting that partial but not complete inactivation of LATS kinases is important for breast cancer development.